Global Cell Line Development for Biologics Supply, Demand and Key Producers, 2023-2029
The global Cell Line Development for Biologics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Cell line development is a critical step in the production of biologics. Biologics are complex molecules that are produced by living cells, such as proteins, antibodies, and vaccines. To produce biologics in large quantities, scientists need to develop cell lines that can produce these molecules consistently and at high levels.
This report studies the global Cell Line Development for Biologics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell Line Development for Biologics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Line Development for Biologics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell Line Development for Biologics total market, 2018-2029, (USD Million)
Global Cell Line Development for Biologics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell Line Development for Biologics total market, key domestic companies and share, (USD Million)
Global Cell Line Development for Biologics revenue by player and market share 2018-2023, (USD Million)
Global Cell Line Development for Biologics total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell Line Development for Biologics total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cell Line Development for Biologics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Corning, Sartorius, Thermo Fisher Scientific, Selexis, Beckman Coulter (Danaher ), CYTENA, Molecular Devices and Samsung Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell Line Development for Biologics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cell Line Development for Biologics Market, By Region:
1. How big is the global Cell Line Development for Biologics market?
2. What is the demand of the global Cell Line Development for Biologics market?
3. What is the year over year growth of the global Cell Line Development for Biologics market?
4. What is the total value of the global Cell Line Development for Biologics market?
5. Who are the major players in the global Cell Line Development for Biologics market?
6. What are the growth factors driving the market demand?
Cell line development is a critical step in the production of biologics. Biologics are complex molecules that are produced by living cells, such as proteins, antibodies, and vaccines. To produce biologics in large quantities, scientists need to develop cell lines that can produce these molecules consistently and at high levels.
This report studies the global Cell Line Development for Biologics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell Line Development for Biologics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Line Development for Biologics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell Line Development for Biologics total market, 2018-2029, (USD Million)
Global Cell Line Development for Biologics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell Line Development for Biologics total market, key domestic companies and share, (USD Million)
Global Cell Line Development for Biologics revenue by player and market share 2018-2023, (USD Million)
Global Cell Line Development for Biologics total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell Line Development for Biologics total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cell Line Development for Biologics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Corning, Sartorius, Thermo Fisher Scientific, Selexis, Beckman Coulter (Danaher ), CYTENA, Molecular Devices and Samsung Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell Line Development for Biologics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cell Line Development for Biologics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- CHO Cell Lines
- HEK293 Cell Lines
- Insect Cell Lines
- Monoclonal Antibodies
- Recombinant Proteins
- Vaccines
- Lonza
- Corning
- Sartorius
- Thermo Fisher Scientific
- Selexis
- Beckman Coulter (Danaher )
- CYTENA
- Molecular Devices
- Samsung Biologics
- Hera BioLabs
- GTP Bioways
- Abzena
- FyoniBio
- Catalent
- WuXi Biologics
1. How big is the global Cell Line Development for Biologics market?
2. What is the demand of the global Cell Line Development for Biologics market?
3. What is the year over year growth of the global Cell Line Development for Biologics market?
4. What is the total value of the global Cell Line Development for Biologics market?
5. Who are the major players in the global Cell Line Development for Biologics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cell Line Development for Biologics Introduction
1.2 World Cell Line Development for Biologics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell Line Development for Biologics Total Market by Region (by Headquarter Location)
1.3.1 World Cell Line Development for Biologics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cell Line Development for Biologics Market Size (2018-2029)
1.3.3 China Cell Line Development for Biologics Market Size (2018-2029)
1.3.4 Europe Cell Line Development for Biologics Market Size (2018-2029)
1.3.5 Japan Cell Line Development for Biologics Market Size (2018-2029)
1.3.6 South Korea Cell Line Development for Biologics Market Size (2018-2029)
1.3.7 ASEAN Cell Line Development for Biologics Market Size (2018-2029)
1.3.8 India Cell Line Development for Biologics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell Line Development for Biologics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell Line Development for Biologics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cell Line Development for Biologics Consumption Value (2018-2029)
2.2 World Cell Line Development for Biologics Consumption Value by Region
2.2.1 World Cell Line Development for Biologics Consumption Value by Region (2018-2023)
2.2.2 World Cell Line Development for Biologics Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell Line Development for Biologics Consumption Value (2018-2029)
2.4 China Cell Line Development for Biologics Consumption Value (2018-2029)
2.5 Europe Cell Line Development for Biologics Consumption Value (2018-2029)
2.6 Japan Cell Line Development for Biologics Consumption Value (2018-2029)
2.7 South Korea Cell Line Development for Biologics Consumption Value (2018-2029)
2.8 ASEAN Cell Line Development for Biologics Consumption Value (2018-2029)
2.9 India Cell Line Development for Biologics Consumption Value (2018-2029)
3 WORLD CELL LINE DEVELOPMENT FOR BIOLOGICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell Line Development for Biologics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell Line Development for Biologics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell Line Development for Biologics in 2022
3.2.3 Global Concentration Ratios (CR8) for Cell Line Development for Biologics in 2022
3.3 Cell Line Development for Biologics Company Evaluation Quadrant
3.4 Cell Line Development for Biologics Market: Overall Company Footprint Analysis
3.4.1 Cell Line Development for Biologics Market: Region Footprint
3.4.2 Cell Line Development for Biologics Market: Company Product Type Footprint
3.4.3 Cell Line Development for Biologics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell Line Development for Biologics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell Line Development for Biologics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cell Line Development for Biologics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell Line Development for Biologics Consumption Value Comparison
4.2.1 United States VS China: Cell Line Development for Biologics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell Line Development for Biologics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell Line Development for Biologics Companies and Market Share, 2018-2023
4.3.1 United States Based Cell Line Development for Biologics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell Line Development for Biologics Revenue, (2018-2023)
4.4 China Based Companies Cell Line Development for Biologics Revenue and Market Share, 2018-2023
4.4.1 China Based Cell Line Development for Biologics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell Line Development for Biologics Revenue, (2018-2023)
4.5 Rest of World Based Cell Line Development for Biologics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cell Line Development for Biologics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cell Line Development for Biologics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell Line Development for Biologics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CHO Cell Lines
5.2.2 HEK293 Cell Lines
5.2.3 Insect Cell Lines
5.3 Market Segment by Type
5.3.1 World Cell Line Development for Biologics Market Size by Type (2018-2023)
5.3.2 World Cell Line Development for Biologics Market Size by Type (2024-2029)
5.3.3 World Cell Line Development for Biologics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cell Line Development for Biologics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Monoclonal Antibodies
6.2.2 Recombinant Proteins
6.2.3 Vaccines
6.3 Market Segment by Application
6.3.1 World Cell Line Development for Biologics Market Size by Application (2018-2023)
6.3.2 World Cell Line Development for Biologics Market Size by Application (2024-2029)
6.3.3 World Cell Line Development for Biologics Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Cell Line Development for Biologics Product and Services
7.1.4 Lonza Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Corning
7.2.1 Corning Details
7.2.2 Corning Major Business
7.2.3 Corning Cell Line Development for Biologics Product and Services
7.2.4 Corning Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Corning Recent Developments/Updates
7.2.6 Corning Competitive Strengths & Weaknesses
7.3 Sartorius
7.3.1 Sartorius Details
7.3.2 Sartorius Major Business
7.3.3 Sartorius Cell Line Development for Biologics Product and Services
7.3.4 Sartorius Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Sartorius Recent Developments/Updates
7.3.6 Sartorius Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Cell Line Development for Biologics Product and Services
7.4.4 Thermo Fisher Scientific Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Selexis
7.5.1 Selexis Details
7.5.2 Selexis Major Business
7.5.3 Selexis Cell Line Development for Biologics Product and Services
7.5.4 Selexis Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Selexis Recent Developments/Updates
7.5.6 Selexis Competitive Strengths & Weaknesses
7.6 Beckman Coulter (Danaher )
7.6.1 Beckman Coulter (Danaher ) Details
7.6.2 Beckman Coulter (Danaher ) Major Business
7.6.3 Beckman Coulter (Danaher ) Cell Line Development for Biologics Product and Services
7.6.4 Beckman Coulter (Danaher ) Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Beckman Coulter (Danaher ) Recent Developments/Updates
7.6.6 Beckman Coulter (Danaher ) Competitive Strengths & Weaknesses
7.7 CYTENA
7.7.1 CYTENA Details
7.7.2 CYTENA Major Business
7.7.3 CYTENA Cell Line Development for Biologics Product and Services
7.7.4 CYTENA Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 CYTENA Recent Developments/Updates
7.7.6 CYTENA Competitive Strengths & Weaknesses
7.8 Molecular Devices
7.8.1 Molecular Devices Details
7.8.2 Molecular Devices Major Business
7.8.3 Molecular Devices Cell Line Development for Biologics Product and Services
7.8.4 Molecular Devices Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Molecular Devices Recent Developments/Updates
7.8.6 Molecular Devices Competitive Strengths & Weaknesses
7.9 Samsung Biologics
7.9.1 Samsung Biologics Details
7.9.2 Samsung Biologics Major Business
7.9.3 Samsung Biologics Cell Line Development for Biologics Product and Services
7.9.4 Samsung Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Samsung Biologics Recent Developments/Updates
7.9.6 Samsung Biologics Competitive Strengths & Weaknesses
7.10 Hera BioLabs
7.10.1 Hera BioLabs Details
7.10.2 Hera BioLabs Major Business
7.10.3 Hera BioLabs Cell Line Development for Biologics Product and Services
7.10.4 Hera BioLabs Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Hera BioLabs Recent Developments/Updates
7.10.6 Hera BioLabs Competitive Strengths & Weaknesses
7.11 GTP Bioways
7.11.1 GTP Bioways Details
7.11.2 GTP Bioways Major Business
7.11.3 GTP Bioways Cell Line Development for Biologics Product and Services
7.11.4 GTP Bioways Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 GTP Bioways Recent Developments/Updates
7.11.6 GTP Bioways Competitive Strengths & Weaknesses
7.12 Abzena
7.12.1 Abzena Details
7.12.2 Abzena Major Business
7.12.3 Abzena Cell Line Development for Biologics Product and Services
7.12.4 Abzena Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Abzena Recent Developments/Updates
7.12.6 Abzena Competitive Strengths & Weaknesses
7.13 FyoniBio
7.13.1 FyoniBio Details
7.13.2 FyoniBio Major Business
7.13.3 FyoniBio Cell Line Development for Biologics Product and Services
7.13.4 FyoniBio Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 FyoniBio Recent Developments/Updates
7.13.6 FyoniBio Competitive Strengths & Weaknesses
7.14 Catalent
7.14.1 Catalent Details
7.14.2 Catalent Major Business
7.14.3 Catalent Cell Line Development for Biologics Product and Services
7.14.4 Catalent Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Catalent Recent Developments/Updates
7.14.6 Catalent Competitive Strengths & Weaknesses
7.15 WuXi Biologics
7.15.1 WuXi Biologics Details
7.15.2 WuXi Biologics Major Business
7.15.3 WuXi Biologics Cell Line Development for Biologics Product and Services
7.15.4 WuXi Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 WuXi Biologics Recent Developments/Updates
7.15.6 WuXi Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cell Line Development for Biologics Industry Chain
8.2 Cell Line Development for Biologics Upstream Analysis
8.3 Cell Line Development for Biologics Midstream Analysis
8.4 Cell Line Development for Biologics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cell Line Development for Biologics Introduction
1.2 World Cell Line Development for Biologics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell Line Development for Biologics Total Market by Region (by Headquarter Location)
1.3.1 World Cell Line Development for Biologics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cell Line Development for Biologics Market Size (2018-2029)
1.3.3 China Cell Line Development for Biologics Market Size (2018-2029)
1.3.4 Europe Cell Line Development for Biologics Market Size (2018-2029)
1.3.5 Japan Cell Line Development for Biologics Market Size (2018-2029)
1.3.6 South Korea Cell Line Development for Biologics Market Size (2018-2029)
1.3.7 ASEAN Cell Line Development for Biologics Market Size (2018-2029)
1.3.8 India Cell Line Development for Biologics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell Line Development for Biologics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell Line Development for Biologics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cell Line Development for Biologics Consumption Value (2018-2029)
2.2 World Cell Line Development for Biologics Consumption Value by Region
2.2.1 World Cell Line Development for Biologics Consumption Value by Region (2018-2023)
2.2.2 World Cell Line Development for Biologics Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell Line Development for Biologics Consumption Value (2018-2029)
2.4 China Cell Line Development for Biologics Consumption Value (2018-2029)
2.5 Europe Cell Line Development for Biologics Consumption Value (2018-2029)
2.6 Japan Cell Line Development for Biologics Consumption Value (2018-2029)
2.7 South Korea Cell Line Development for Biologics Consumption Value (2018-2029)
2.8 ASEAN Cell Line Development for Biologics Consumption Value (2018-2029)
2.9 India Cell Line Development for Biologics Consumption Value (2018-2029)
3 WORLD CELL LINE DEVELOPMENT FOR BIOLOGICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell Line Development for Biologics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell Line Development for Biologics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell Line Development for Biologics in 2022
3.2.3 Global Concentration Ratios (CR8) for Cell Line Development for Biologics in 2022
3.3 Cell Line Development for Biologics Company Evaluation Quadrant
3.4 Cell Line Development for Biologics Market: Overall Company Footprint Analysis
3.4.1 Cell Line Development for Biologics Market: Region Footprint
3.4.2 Cell Line Development for Biologics Market: Company Product Type Footprint
3.4.3 Cell Line Development for Biologics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell Line Development for Biologics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell Line Development for Biologics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cell Line Development for Biologics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell Line Development for Biologics Consumption Value Comparison
4.2.1 United States VS China: Cell Line Development for Biologics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell Line Development for Biologics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell Line Development for Biologics Companies and Market Share, 2018-2023
4.3.1 United States Based Cell Line Development for Biologics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell Line Development for Biologics Revenue, (2018-2023)
4.4 China Based Companies Cell Line Development for Biologics Revenue and Market Share, 2018-2023
4.4.1 China Based Cell Line Development for Biologics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell Line Development for Biologics Revenue, (2018-2023)
4.5 Rest of World Based Cell Line Development for Biologics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cell Line Development for Biologics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cell Line Development for Biologics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell Line Development for Biologics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CHO Cell Lines
5.2.2 HEK293 Cell Lines
5.2.3 Insect Cell Lines
5.3 Market Segment by Type
5.3.1 World Cell Line Development for Biologics Market Size by Type (2018-2023)
5.3.2 World Cell Line Development for Biologics Market Size by Type (2024-2029)
5.3.3 World Cell Line Development for Biologics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cell Line Development for Biologics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Monoclonal Antibodies
6.2.2 Recombinant Proteins
6.2.3 Vaccines
6.3 Market Segment by Application
6.3.1 World Cell Line Development for Biologics Market Size by Application (2018-2023)
6.3.2 World Cell Line Development for Biologics Market Size by Application (2024-2029)
6.3.3 World Cell Line Development for Biologics Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Cell Line Development for Biologics Product and Services
7.1.4 Lonza Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Corning
7.2.1 Corning Details
7.2.2 Corning Major Business
7.2.3 Corning Cell Line Development for Biologics Product and Services
7.2.4 Corning Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Corning Recent Developments/Updates
7.2.6 Corning Competitive Strengths & Weaknesses
7.3 Sartorius
7.3.1 Sartorius Details
7.3.2 Sartorius Major Business
7.3.3 Sartorius Cell Line Development for Biologics Product and Services
7.3.4 Sartorius Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Sartorius Recent Developments/Updates
7.3.6 Sartorius Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Cell Line Development for Biologics Product and Services
7.4.4 Thermo Fisher Scientific Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Selexis
7.5.1 Selexis Details
7.5.2 Selexis Major Business
7.5.3 Selexis Cell Line Development for Biologics Product and Services
7.5.4 Selexis Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Selexis Recent Developments/Updates
7.5.6 Selexis Competitive Strengths & Weaknesses
7.6 Beckman Coulter (Danaher )
7.6.1 Beckman Coulter (Danaher ) Details
7.6.2 Beckman Coulter (Danaher ) Major Business
7.6.3 Beckman Coulter (Danaher ) Cell Line Development for Biologics Product and Services
7.6.4 Beckman Coulter (Danaher ) Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Beckman Coulter (Danaher ) Recent Developments/Updates
7.6.6 Beckman Coulter (Danaher ) Competitive Strengths & Weaknesses
7.7 CYTENA
7.7.1 CYTENA Details
7.7.2 CYTENA Major Business
7.7.3 CYTENA Cell Line Development for Biologics Product and Services
7.7.4 CYTENA Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 CYTENA Recent Developments/Updates
7.7.6 CYTENA Competitive Strengths & Weaknesses
7.8 Molecular Devices
7.8.1 Molecular Devices Details
7.8.2 Molecular Devices Major Business
7.8.3 Molecular Devices Cell Line Development for Biologics Product and Services
7.8.4 Molecular Devices Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Molecular Devices Recent Developments/Updates
7.8.6 Molecular Devices Competitive Strengths & Weaknesses
7.9 Samsung Biologics
7.9.1 Samsung Biologics Details
7.9.2 Samsung Biologics Major Business
7.9.3 Samsung Biologics Cell Line Development for Biologics Product and Services
7.9.4 Samsung Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Samsung Biologics Recent Developments/Updates
7.9.6 Samsung Biologics Competitive Strengths & Weaknesses
7.10 Hera BioLabs
7.10.1 Hera BioLabs Details
7.10.2 Hera BioLabs Major Business
7.10.3 Hera BioLabs Cell Line Development for Biologics Product and Services
7.10.4 Hera BioLabs Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Hera BioLabs Recent Developments/Updates
7.10.6 Hera BioLabs Competitive Strengths & Weaknesses
7.11 GTP Bioways
7.11.1 GTP Bioways Details
7.11.2 GTP Bioways Major Business
7.11.3 GTP Bioways Cell Line Development for Biologics Product and Services
7.11.4 GTP Bioways Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 GTP Bioways Recent Developments/Updates
7.11.6 GTP Bioways Competitive Strengths & Weaknesses
7.12 Abzena
7.12.1 Abzena Details
7.12.2 Abzena Major Business
7.12.3 Abzena Cell Line Development for Biologics Product and Services
7.12.4 Abzena Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Abzena Recent Developments/Updates
7.12.6 Abzena Competitive Strengths & Weaknesses
7.13 FyoniBio
7.13.1 FyoniBio Details
7.13.2 FyoniBio Major Business
7.13.3 FyoniBio Cell Line Development for Biologics Product and Services
7.13.4 FyoniBio Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 FyoniBio Recent Developments/Updates
7.13.6 FyoniBio Competitive Strengths & Weaknesses
7.14 Catalent
7.14.1 Catalent Details
7.14.2 Catalent Major Business
7.14.3 Catalent Cell Line Development for Biologics Product and Services
7.14.4 Catalent Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Catalent Recent Developments/Updates
7.14.6 Catalent Competitive Strengths & Weaknesses
7.15 WuXi Biologics
7.15.1 WuXi Biologics Details
7.15.2 WuXi Biologics Major Business
7.15.3 WuXi Biologics Cell Line Development for Biologics Product and Services
7.15.4 WuXi Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 WuXi Biologics Recent Developments/Updates
7.15.6 WuXi Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cell Line Development for Biologics Industry Chain
8.2 Cell Line Development for Biologics Upstream Analysis
8.3 Cell Line Development for Biologics Midstream Analysis
8.4 Cell Line Development for Biologics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cell Line Development for Biologics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell Line Development for Biologics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell Line Development for Biologics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell Line Development for Biologics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell Line Development for Biologics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell Line Development for Biologics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell Line Development for Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell Line Development for Biologics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell Line Development for Biologics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell Line Development for Biologics Players in 2022
Table 12. World Cell Line Development for Biologics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell Line Development for Biologics Company Evaluation Quadrant
Table 14. Head Office of Key Cell Line Development for Biologics Player
Table 15. Cell Line Development for Biologics Market: Company Product Type Footprint
Table 16. Cell Line Development for Biologics Market: Company Product Application Footprint
Table 17. Cell Line Development for Biologics Mergers & Acquisitions Activity
Table 18. United States VS China Cell Line Development for Biologics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell Line Development for Biologics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell Line Development for Biologics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell Line Development for Biologics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell Line Development for Biologics Revenue Market Share (2018-2023)
Table 23. China Based Cell Line Development for Biologics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell Line Development for Biologics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell Line Development for Biologics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell Line Development for Biologics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell Line Development for Biologics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell Line Development for Biologics Revenue Market Share (2018-2023)
Table 29. World Cell Line Development for Biologics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell Line Development for Biologics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell Line Development for Biologics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell Line Development for Biologics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell Line Development for Biologics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cell Line Development for Biologics Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Cell Line Development for Biologics Product and Services
Table 38. Lonza Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Corning Basic Information, Area Served and Competitors
Table 42. Corning Major Business
Table 43. Corning Cell Line Development for Biologics Product and Services
Table 44. Corning Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Corning Recent Developments/Updates
Table 46. Corning Competitive Strengths & Weaknesses
Table 47. Sartorius Basic Information, Area Served and Competitors
Table 48. Sartorius Major Business
Table 49. Sartorius Cell Line Development for Biologics Product and Services
Table 50. Sartorius Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Sartorius Recent Developments/Updates
Table 52. Sartorius Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Cell Line Development for Biologics Product and Services
Table 56. Thermo Fisher Scientific Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Selexis Basic Information, Area Served and Competitors
Table 60. Selexis Major Business
Table 61. Selexis Cell Line Development for Biologics Product and Services
Table 62. Selexis Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Selexis Recent Developments/Updates
Table 64. Selexis Competitive Strengths & Weaknesses
Table 65. Beckman Coulter (Danaher ) Basic Information, Area Served and Competitors
Table 66. Beckman Coulter (Danaher ) Major Business
Table 67. Beckman Coulter (Danaher ) Cell Line Development for Biologics Product and Services
Table 68. Beckman Coulter (Danaher ) Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Beckman Coulter (Danaher ) Recent Developments/Updates
Table 70. Beckman Coulter (Danaher ) Competitive Strengths & Weaknesses
Table 71. CYTENA Basic Information, Area Served and Competitors
Table 72. CYTENA Major Business
Table 73. CYTENA Cell Line Development for Biologics Product and Services
Table 74. CYTENA Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. CYTENA Recent Developments/Updates
Table 76. CYTENA Competitive Strengths & Weaknesses
Table 77. Molecular Devices Basic Information, Area Served and Competitors
Table 78. Molecular Devices Major Business
Table 79. Molecular Devices Cell Line Development for Biologics Product and Services
Table 80. Molecular Devices Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Molecular Devices Recent Developments/Updates
Table 82. Molecular Devices Competitive Strengths & Weaknesses
Table 83. Samsung Biologics Basic Information, Area Served and Competitors
Table 84. Samsung Biologics Major Business
Table 85. Samsung Biologics Cell Line Development for Biologics Product and Services
Table 86. Samsung Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Samsung Biologics Recent Developments/Updates
Table 88. Samsung Biologics Competitive Strengths & Weaknesses
Table 89. Hera BioLabs Basic Information, Area Served and Competitors
Table 90. Hera BioLabs Major Business
Table 91. Hera BioLabs Cell Line Development for Biologics Product and Services
Table 92. Hera BioLabs Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Hera BioLabs Recent Developments/Updates
Table 94. Hera BioLabs Competitive Strengths & Weaknesses
Table 95. GTP Bioways Basic Information, Area Served and Competitors
Table 96. GTP Bioways Major Business
Table 97. GTP Bioways Cell Line Development for Biologics Product and Services
Table 98. GTP Bioways Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. GTP Bioways Recent Developments/Updates
Table 100. GTP Bioways Competitive Strengths & Weaknesses
Table 101. Abzena Basic Information, Area Served and Competitors
Table 102. Abzena Major Business
Table 103. Abzena Cell Line Development for Biologics Product and Services
Table 104. Abzena Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Abzena Recent Developments/Updates
Table 106. Abzena Competitive Strengths & Weaknesses
Table 107. FyoniBio Basic Information, Area Served and Competitors
Table 108. FyoniBio Major Business
Table 109. FyoniBio Cell Line Development for Biologics Product and Services
Table 110. FyoniBio Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. FyoniBio Recent Developments/Updates
Table 112. FyoniBio Competitive Strengths & Weaknesses
Table 113. Catalent Basic Information, Area Served and Competitors
Table 114. Catalent Major Business
Table 115. Catalent Cell Line Development for Biologics Product and Services
Table 116. Catalent Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Catalent Recent Developments/Updates
Table 118. WuXi Biologics Basic Information, Area Served and Competitors
Table 119. WuXi Biologics Major Business
Table 120. WuXi Biologics Cell Line Development for Biologics Product and Services
Table 121. WuXi Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Cell Line Development for Biologics Upstream (Raw Materials)
Table 123. Cell Line Development for Biologics Typical Customers
Table 1. World Cell Line Development for Biologics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell Line Development for Biologics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell Line Development for Biologics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell Line Development for Biologics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell Line Development for Biologics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell Line Development for Biologics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell Line Development for Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell Line Development for Biologics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell Line Development for Biologics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell Line Development for Biologics Players in 2022
Table 12. World Cell Line Development for Biologics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell Line Development for Biologics Company Evaluation Quadrant
Table 14. Head Office of Key Cell Line Development for Biologics Player
Table 15. Cell Line Development for Biologics Market: Company Product Type Footprint
Table 16. Cell Line Development for Biologics Market: Company Product Application Footprint
Table 17. Cell Line Development for Biologics Mergers & Acquisitions Activity
Table 18. United States VS China Cell Line Development for Biologics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell Line Development for Biologics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell Line Development for Biologics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell Line Development for Biologics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell Line Development for Biologics Revenue Market Share (2018-2023)
Table 23. China Based Cell Line Development for Biologics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell Line Development for Biologics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell Line Development for Biologics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell Line Development for Biologics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell Line Development for Biologics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell Line Development for Biologics Revenue Market Share (2018-2023)
Table 29. World Cell Line Development for Biologics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell Line Development for Biologics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell Line Development for Biologics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell Line Development for Biologics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell Line Development for Biologics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cell Line Development for Biologics Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Cell Line Development for Biologics Product and Services
Table 38. Lonza Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Corning Basic Information, Area Served and Competitors
Table 42. Corning Major Business
Table 43. Corning Cell Line Development for Biologics Product and Services
Table 44. Corning Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Corning Recent Developments/Updates
Table 46. Corning Competitive Strengths & Weaknesses
Table 47. Sartorius Basic Information, Area Served and Competitors
Table 48. Sartorius Major Business
Table 49. Sartorius Cell Line Development for Biologics Product and Services
Table 50. Sartorius Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Sartorius Recent Developments/Updates
Table 52. Sartorius Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Cell Line Development for Biologics Product and Services
Table 56. Thermo Fisher Scientific Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Selexis Basic Information, Area Served and Competitors
Table 60. Selexis Major Business
Table 61. Selexis Cell Line Development for Biologics Product and Services
Table 62. Selexis Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Selexis Recent Developments/Updates
Table 64. Selexis Competitive Strengths & Weaknesses
Table 65. Beckman Coulter (Danaher ) Basic Information, Area Served and Competitors
Table 66. Beckman Coulter (Danaher ) Major Business
Table 67. Beckman Coulter (Danaher ) Cell Line Development for Biologics Product and Services
Table 68. Beckman Coulter (Danaher ) Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Beckman Coulter (Danaher ) Recent Developments/Updates
Table 70. Beckman Coulter (Danaher ) Competitive Strengths & Weaknesses
Table 71. CYTENA Basic Information, Area Served and Competitors
Table 72. CYTENA Major Business
Table 73. CYTENA Cell Line Development for Biologics Product and Services
Table 74. CYTENA Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. CYTENA Recent Developments/Updates
Table 76. CYTENA Competitive Strengths & Weaknesses
Table 77. Molecular Devices Basic Information, Area Served and Competitors
Table 78. Molecular Devices Major Business
Table 79. Molecular Devices Cell Line Development for Biologics Product and Services
Table 80. Molecular Devices Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Molecular Devices Recent Developments/Updates
Table 82. Molecular Devices Competitive Strengths & Weaknesses
Table 83. Samsung Biologics Basic Information, Area Served and Competitors
Table 84. Samsung Biologics Major Business
Table 85. Samsung Biologics Cell Line Development for Biologics Product and Services
Table 86. Samsung Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Samsung Biologics Recent Developments/Updates
Table 88. Samsung Biologics Competitive Strengths & Weaknesses
Table 89. Hera BioLabs Basic Information, Area Served and Competitors
Table 90. Hera BioLabs Major Business
Table 91. Hera BioLabs Cell Line Development for Biologics Product and Services
Table 92. Hera BioLabs Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Hera BioLabs Recent Developments/Updates
Table 94. Hera BioLabs Competitive Strengths & Weaknesses
Table 95. GTP Bioways Basic Information, Area Served and Competitors
Table 96. GTP Bioways Major Business
Table 97. GTP Bioways Cell Line Development for Biologics Product and Services
Table 98. GTP Bioways Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. GTP Bioways Recent Developments/Updates
Table 100. GTP Bioways Competitive Strengths & Weaknesses
Table 101. Abzena Basic Information, Area Served and Competitors
Table 102. Abzena Major Business
Table 103. Abzena Cell Line Development for Biologics Product and Services
Table 104. Abzena Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Abzena Recent Developments/Updates
Table 106. Abzena Competitive Strengths & Weaknesses
Table 107. FyoniBio Basic Information, Area Served and Competitors
Table 108. FyoniBio Major Business
Table 109. FyoniBio Cell Line Development for Biologics Product and Services
Table 110. FyoniBio Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. FyoniBio Recent Developments/Updates
Table 112. FyoniBio Competitive Strengths & Weaknesses
Table 113. Catalent Basic Information, Area Served and Competitors
Table 114. Catalent Major Business
Table 115. Catalent Cell Line Development for Biologics Product and Services
Table 116. Catalent Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Catalent Recent Developments/Updates
Table 118. WuXi Biologics Basic Information, Area Served and Competitors
Table 119. WuXi Biologics Major Business
Table 120. WuXi Biologics Cell Line Development for Biologics Product and Services
Table 121. WuXi Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Cell Line Development for Biologics Upstream (Raw Materials)
Table 123. Cell Line Development for Biologics Typical Customers
LIST OF FIGURES
Figure 1. Cell Line Development for Biologics Picture
Figure 2. World Cell Line Development for Biologics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell Line Development for Biologics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell Line Development for Biologics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell Line Development for Biologics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 13. Cell Line Development for Biologics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell Line Development for Biologics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell Line Development for Biologics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell Line Development for Biologics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell Line Development for Biologics Markets in 2022
Figure 27. United States VS China: Cell Line Development for Biologics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell Line Development for Biologics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell Line Development for Biologics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell Line Development for Biologics Market Size Market Share by Type in 2022
Figure 31. CHO Cell Lines
Figure 32. HEK293 Cell Lines
Figure 33. Insect Cell Lines
Figure 34. World Cell Line Development for Biologics Market Size Market Share by Type (2018-2029)
Figure 35. World Cell Line Development for Biologics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Cell Line Development for Biologics Market Size Market Share by Application in 2022
Figure 37. Monoclonal Antibodies
Figure 38. Recombinant Proteins
Figure 39. Vaccines
Figure 40. Cell Line Development for Biologics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Cell Line Development for Biologics Picture
Figure 2. World Cell Line Development for Biologics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell Line Development for Biologics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell Line Development for Biologics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell Line Development for Biologics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell Line Development for Biologics Revenue (2018-2029) & (USD Million)
Figure 13. Cell Line Development for Biologics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell Line Development for Biologics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell Line Development for Biologics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell Line Development for Biologics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell Line Development for Biologics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell Line Development for Biologics Markets in 2022
Figure 27. United States VS China: Cell Line Development for Biologics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell Line Development for Biologics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell Line Development for Biologics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell Line Development for Biologics Market Size Market Share by Type in 2022
Figure 31. CHO Cell Lines
Figure 32. HEK293 Cell Lines
Figure 33. Insect Cell Lines
Figure 34. World Cell Line Development for Biologics Market Size Market Share by Type (2018-2029)
Figure 35. World Cell Line Development for Biologics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Cell Line Development for Biologics Market Size Market Share by Application in 2022
Figure 37. Monoclonal Antibodies
Figure 38. Recombinant Proteins
Figure 39. Vaccines
Figure 40. Cell Line Development for Biologics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
